Search Results - M. Potrony
- Showing 1 - 4 results of 4
-
1
Phenocopies in melanoma families with germline mutations in CDKN2A are associated to MC1R polymorphisms and high total body nevus count by A. Luna, E. Serra, A. Abarzúa, M. Potrony, C. Badenas, S. Podlipnik, C. Carrera, J. Malvehy, S. Puig, P. Aguilera
Published in EJC Skin Cancer (2024-01-01)Get full text
Article -
2
Unraveling the Impact of Microbiome on Immunotherapy Efficacy in Melanoma by J. Bagué Companys, T. Torres Moral, J. Mateu, M. Potrony, N. Calbet, P. Iglesias, C. Carrera, J. Malvehy, S. Puig
Published in EJC Skin Cancer (2024-01-01)Get full text
Article -
3
Benefit of immunotherapy for advanced melanoma in two patients with xeroderma pigmentosum by A.C. Rivas Segovia, G. Gargantini Rezze, C. Carrera, M. Potrony, J. Malvehy, R.M. Huertas, F. Aya, J. Mestres, S. Podlipnik, A.M. Arance, L. Alos, S. Puig
Published in EJC Skin Cancer (2024-01-01)Get full text
Article -
4
Melanoma in Children, Adolescents, and Young Adults: The Spanish Cohort of the MELCAYA Consortium by R.M. Patricio da Silva-Junior, J. Ficapal, M. Potrony, T. Torres, M.E. Gil, J. Bague, J. Mateu, F. Crespi-Payeras, S. Podlipnik, J.A. Puig, P. Aguilera, C. Carrera, L. Alòs, J. Malvehy, S. Puig
Published in EJC Skin Cancer (2024-01-01)Get full text
Article
